Concurrent use of mifepristone and misoprostol for early medical abortion

Taiwanese Journal of Obstetrics and Gynecology

Volumn 45, Issue 4, 2006, Pages 325-328

  Li, Yiu Tai ^a   Chen, Fu Min ^b   Chen, Tien Hui ^a   Li, Shu Ching ^a   Chen, Min Lung ^a   Kuo, Tsung Cheng ^a  

^a KUO GENERAL HOSPITAL   (Taiwan)

^b Chung Shan Hospital   (Taiwan)

Author keywords

Concurrent medical abortion; Mifepristone; Misoprostol

Indexed keywords

MIFEPRISTONE; MISOPROSTOL; PARACETAMOL;

ABDOMINAL PAIN; ABORTION; ARTICLE; BLEEDING; CONTROLLED STUDY; DIARRHEA; DISEASE DURATION; DOSE RESPONSE; DRUG EFFICACY; DRUG USE; FEMALE; FEVER; FOLLOW UP; GESTATION PERIOD; HEADACHE; HUMAN; INFECTION; LOWER ABDOMINAL PAIN; MAJOR CLINICAL STUDY; NAUSEA; PATIENT SATISFACTION; SHIVERING; TABLET FORMULATION; TRANSVAGINAL ECHOGRAPHY; UNWANTED PREGNANCY; VOMITING;

EID: 33846284478     PISSN: 10284559     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1028-4559(09)60252-7     Document Type: Article

References (13)

1. El-Refaey H, Rajasekar D, Abdalla M, Calder L, Templeton A. Induction of abortion with mifepristone (RU486) and oral or vaginal misoprostol. N Engl J Med 1995;332:983-7.
2. Peyron R, Aubeny E, Targosz V, et al. Early termination of pregnancy with mifepristone (RU486) and the orally active prostaglandin misoprostol. N Engl J Med 1993;328:1509-13.
3. Kahn JG, Beaker BJ, MacIsaa L, et al. The efficacy of medical abortion: a meta-analysis. Contraception 2000;61:29-40.
4. Lin HW, Chien TY, Jeng CJ, Chen SC, Chen HF, Hwang JL. Comparison of two doses of mifepristone in combination with misoprostol for early pregnancy termination. Taiwanese J Obstet Gynecol 2002;41:155-61.
5. Swahn ML, Wang C, Aedo AR, Cekan SZ, Bygdeman M. Plasma levels of antiprogestin RU 486 following oral administration to non-pregnant and early pregnant women. Contraception 1986;34:469-81.
6. Shi YE, Ye ZH, He CH, et al. Pharmacokinetic study of RU 486 and its metabolite after oral administration of single doses to pregnant and non-pregnant women. Contraception 1993;48:133-49.
7. Marions L. Mifepristone dose in the regimen for medical abortion. Contraception 2006;74:21-5.
8. Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol 1997;90:88-92.
9. Schaff E. Evidence for shortening the time interval of prostaglandin after mifepristone for medical abortion. Contraception 2006;74:42-4.
10. Jain JK, Dutton C, Harwood B, Meckstroth KR, Mishell DR Jr. A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy. Hum Reprod 2002;17:1477-82.
11. Murthy AS, Creinin MD, Harwood B, Schreiber C. A pilot study of mifepristone and misoprostol administered at the same time for abortion up to 49 days gestation. Contraception 2005;71:333-6.
12. Schreiber CA, Creinin MD, Harwood B, Murthy AS. A pilot study of mifepristone and misoprostol administered at the same time for abortion in women with gestation from 50 to 63 days. Contraception 2005;71:447-50.
13. Kapp N, Borgatta L, Ellis SC, Stubblefield P. Simultaneous very low dose mifepristone and vaginal misoprostol for medical abortion. Contraception 2006;73:525-7.